Placental Abruption and Perinatal Outcomes

Placental abruption is the premature separation of the placenta from the uterine wall before delivery, a condition that disrupts maternal–fetal exchange and threatens both lives. It complicates approximately 1–2% of pregnancies worldwide and remains a leading cause of antepartum haemorrhage, preterm birth and perinatal mortality. Established risk factors include hypertension, preeclampsia, smoking, trauma, high parity and a history of previous abruption. Clinically, patients may present with vaginal bleeding, abdominal pain and uterine tenderness, while fetal distress often manifests as heart rate abnormalities. Histopathological features of maternal vascular malperfusion and intervillous thrombosis underpin impaired oxygen and nutrient delivery. Adverse outcomes extend from low birth weight and neonatal intensive care admission to longer-term neurodevelopmental impairment. Early recognition, vigilant monitoring and timely obstetric intervention are essential to reduce maternal morbidity and improve neonatal survival.

Research from Nature Portfolio

Recent studies have elucidated the interplay between maternal cardiovascular conditions and abruption risk. Histopathological analysis of placentas from women with congenital heart disease reveals a high prevalence of maternal vascular malperfusion and subchorionic haematoma, with placental separation occurring in over one in ten cases despite varying cardiovascular risk status. These findings underscore the importance of tailored surveillance for placental health in pregnancies complicated by maternal heart disease and point to shared pathways of vascular dysfunction that heighten the risk of preterm delivery and foetal growth restriction.

Placental Abruption and Perinatal Outcomes publication trend

The graph below shows the total number of articles in placental abruption and perinatal outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Placental abruption: Premature detachment of the placenta from the uterine wall, compromising foetal oxygenation and maternal haemostasis.

Maternal vascular malperfusion: Histopathological pattern reflecting impaired maternal blood flow through the placenta, often seen in hypertensive disorders.

Small for gestational age (SGA): Foetus or neonate with weight below the 10th percentile for its gestational age, indicating intrauterine growth restriction.

Perinatal mortality: Combined measure of fetal death (stillbirth) and early neonatal death, typically from 22 weeks’ gestation to seven days after birth.

Histopathological evaluation: Microscopic examination of placental tissue to identify structural abnormalities and vascular lesions.

References

1. Vascular malperfusion and abruption are prevalent in placentas from pregnancies with congenital heart disease and not associated with cardiovascular risk. Scientific Reports (2023).
2. Perinatal outcomes and predictors of placental abruption: a retrospective study in an Ethiopian tertiary care center. Frontiers in Public Health (2025).
3. Relationship between Abnormal Placenta and Obstetric Outcomes: A Meta-Analysis. Biomedicines (2023).
4. An International Contrast of Rates of Placental Abruption: An Age-Period-Cohort Analysis. PLOS ONE (2015).